NEW ANTIBIOTIC COULD TARGET DRUG-RESISTANT BACTERIUM
Why in the News?
- Researchers at the University of Illinois, Urbana-Champaign, have discovered a new class of antibiotics.
Source: CNN
- Target Bacterium: Acinetobacter baumannii (CRAB – Carbapenem-Resistant Acinetobacter baumannii)
- Effective Antibiotic: Zosurabalpin
Mode of Action:
- Zosurabalpin works against CRAB with a novel mechanism.
- It inhibits the transport of lipopolysaccharide (LPS) by targeting a complex of proteins.
- This disruption of LPS transport leads to the destruction of the outer-membrane structure of Gram-negative bacteria, killing A. baumannii.
Promising Results:
- Zosurabalpin demonstrated effectiveness against CRAB-induced pneumonia and sepsis in mouse models.
- Researchers optimized and fine-tuned Zosurabalpin for improved efficacy and tolerability.
- The compound shows promise as a potential drug candidate for treating drug-resistant bacterial infections.
- Zosurabalpin was effective against more than 100 clinical samples of CRAB.
- It considerably reduced bacterial levels in mice with CRAB-induced pneumonia, preventing sepsis and abnormal immune responses.